Retina/Vitreous
Doheny's Retina/Vitreous Service consists of comprehensive consultative,
medical and surgical care. The group specializes in the repair of complex
retinal detachments, offering advanced techniques such as silicone oil,
perfluorocarbon liquids and SF6 and C3F8 gases. The group is particularly
well equipped to repair penetrating trauma, drawing from its members'
vast surgical and research experience. Laser treatment of the retina
for diabetic retinopathy can be performed with the argon, krypton, diode,
or double frequency YAG laser. Extensive diagnostic services are available
through our ancillary services departments.
Doheny faculty members are leading researchers in retinal transplantation,
imaging of ocular disease and age-related macular degeneration.
 |
Rizwan Bhatti, MD
Clinical Specialties
Medical and surgical areas of retina vitreous with special interests in
age-related macular degeneration, diabetic retinopathy and complex retinal detachments. Dr. Bhatti is a co-investigator in a number of clinical trials for macular degeneration, diabetic retinopathy, and retinal vascular diseases.
He is currently the Director of the Doheny Eye Center in the Coachella Valley in Southern California.
Academic Degrees
Medical College of Ohio, Toledo, OH
Residency
Henry For Hospital Deprtment of Ophthalmology
Chief Resident, July 2004-June 2005
Fellowships
Doheny Retina Institute, University of Southern California,
Doheny Eye Institute Vitreo-Retinal Surgical Fellowship
Board Certification
American Board of Ophthalmology
Research Activities
Dr. Bhatti serves as an investigator in the Doheny Image Reading Center. In addition, he is studying different surgical instrumentation for vitreous surgery with a special interest in the endoscopic evaluation of surgical sclerotomies.
|
| |
|
 |
Lawrence Chong, MD
Dr. Chong earned a M.D. from Harvard University. He completed
his residency at Doheny Eye Institute, University of Southern
California, and his retina-vitreous fellowship at the Duke University
Eye Center. He returned to the Doheny Eye Institute as chief resident
before joining the faculty. His research interests include AIDS
retinopathy, macular degeneration, retinal pigment epithelial
selective lasers and dye enhanced laser treatment of ocular tumors.
Dr.
Chong's research in the sustained release of ganciclovir for CMV retinitis
represents a breakthrough in AIDS research since it involves implantation
of a device into the eye to allow for the slow release of drugs over
an extended period of time. This benefits those patients who cannot
tolerate systemic, intravenous drugs.Dr. Chong is Chief of the Retina Service at the Doheny Eye Institute
and Associate Professor of Ophthalmology at the USC Keck School
of Medicine. |
| |
|
 |
Dean Eliott, MD
Professor of Ophthalmology, Director of Clinical Affairs of the Doheny Retina Institute
Fellowships
Duke University Eye Center;
Duke University Medical Center, Durham, NC;Vitreoretinal Surgery;1992 - 1993
Residencies
The Wilmer Ophthalmological Institute,
The Johns Hopkins Hospital, Baltimore, ;Ophthalmology;1989 - 1992
Academics
Vanderbilt University School of Medicine ;Doctor of Medicine;1984 - 1988
Clinical Specialties
Diabetic retinopathy, macular degeneration, complex retinal detachment, surgery for complex retina-vitreous disorders and ocular trauma.
Research
Diabetic retinopathy, macular degeneration, complex retinal detachment, surgery for complex retina-vitreous disorders and ocular trauma.
Internships
Cornell University Medical Center, New York Hospital,
Memorial Sloan-Kettering Cancer Center, Hospital for Special Surgery, New York, NY Internal Medicine 1988 - 1989
Appointments
LosAngeles
Rancho Mirage
Pasadena
|
| |
|
 |
Amani Fawzi, MD
Assistant Professor of Ophthalmology
Clinical Specialties
Surgical and medical management of complex retinal disease
Surgical and medical management of posterior uveitis
Academic Degrees
M.B.,B.Ch. Cairo University Medical School, Egypt, 1986-1992
M.Sc. Cairo University Medical School, Egypt, 1997
D.Sc. Cairo University Medical School, Egypt, 2000
Residency
Cairo University Hospitals, 1994-1997
Jules Stein Eye Institute, UCLA, 2001-2004
Fellowships
Research and Medical Retina ( Retinal Degenerations),
Jules Stein Eye Institute, UCLA, 1998-2000
Vitreoretinal disease and surgery, Doheny Retina Institute, Keck School of Medicine, University of Southern California, 2004-2006
Board Certification
American Board of Ophthalmology
Research Activities
Functional retinal imaging in health and disease
High-speed, high-resolution OCT imaging in retinal disease
Molecular imaging of the retina
Novel therapeutic approaches to ischemic retinal disease
Electrophysiology and Retinal Degenerations
|
| |
|
 |
Mark Humayun, MD, PhD
Dr. Humayun completed his medical degree at Duke University Medical
School. While in his residency training at Duke Eye Center, Dr.
Humayun earned his Ph.D. in Biomedical Engineering at the University
of North Carolina at Chapel Hill. He completed his fellowship training
in vitreoretinal disease at the Wilmer Ophthalmological Institute
at Johns Hopkins. Dr. Humayun served most recently at the Wilmer
Ophthalmological Institute at Johns Hopkins as an Associate Professor
and as Director of the Intraocular Retinal Prosthesis Lab. The focus
of this lab is to develop a retinal implant for the blind. He has
had a close working relationship with Biomedical Engineering and
a number of national labs such as Naval Research Laboratory and
Oakridge National Laboratory. |
| |
|
 |
Linda Lam, MD
Dr. Lam attended medical school at Cornell University Medical College. During medical school, she completed a one year research fellowship investigating the protein sorting pathways in retinal pigment epithelium cells.
Dr. Lam further pursued her interest in retinal research during her ophthalmology residency at Cole Eye Institute at the Cleveland Clinic Foundation. Dr. Lam then completed a two-year combined fellowship program in vitreoretinal diseases and surgery at Georgetown University Hospital, Washington Hospital Center, and Retina Group of Washington. An area of particular interest is mechanisms of retinal physiology and degeneration. Dr. Lam's primary clinical research interests are developing treatments for macular degeneration, as well as exploring both medical and surgical modalities for the treatment of diabetic retinopathy and proliferative vitreoretinopathy. Dr. Lam serves as the Medical Director at the Doheny Retina Center in Riverside. |
| |
|
 |
A. L inn Murphree, MD
Education
Doctor of Medicine, Medicine, Baylor College of Medicine, 1972
Residencies
Baylor College Affiliated Hospitals - Ophthalmology, 1973 - 1976
Baylor College Affiliated Hospitals, Houston, TX, Chief Resident - Opthalmology, 1975 - 1976
Fellowships
University of Copenhagen, Denmark, Fulbright Scholar - Human Genetics, 1967 - 1968
Baylor College Affiliated Hospitals - Medical Genetics, 1972 - 1973
Board Certification
American Board of Ophthalmology, 1978
Professional Society Memberships
American Academy of Ophthalmology
American Academy of Pediatrics
American Association of Pediatric and Strabismus
Clinical Interests
Ocular oncology
Retinoblastoma
Ophthalmology
|
| |
|
 |
Carmen A. Puliafito, MD, MBA
Dean
May S. and John Hooval Dean's Chair in Medicine
Professor of Ophthalmology & Health Management
Clinical Specialties
Macular Degeneration
Diabetic Retinopathy
Macular Diseases
Retinitis Pigmentosa and Retinal Degenerations
Vitreoretinal Diseases and Surgery
Academic Degrees
M.D., Harvard Medical School, Boston MA
M.B.A., The Wharton School of the University of Pennsylvania, Philadelphia, PA
Residency
Massachusetts Eye and Ear Infirmary
Harvard University, Boston, MA
Fellowships
Ophthalmic Pathology, Howe Laboratory of Ophthalmology, Harvard Medical School, Boston, MA
Vitreoretinal Diseases and Surgery,
Massachusetts Eye and Ear Infirmary, Boston, MA
Board Certification
American Board of Ophthalmology
Research Activities
Retinal photocoagulation, vitreous surgery
for complicated retinal detachment and trauma, macular degeneration, diabetic retinopathy and the application of new laser technologies to the eye
|
| |
|
 |
Stephen J. Ryan, MD
Dr. Ryan earned an M.D. from the Johns Hopkins University School
of Medicine. He completed his residency and chief residency at the
Wilmer Ophthalmological Institute, Johns Hopkins Hospital, and his
fellowship in ophthalmic pathology at the Armed Forces Institute
of Pathology. Dr. Ryan is the past Dean of the Keck School of Medicine at USC. He is the President of Doheny Eye Institute and a Professor of Ophthalmology. He continues to maintain a clinical
practice with an emphasis on retina and macular disease and ocular
trauma. |
| |
|
 |
SriniVas Sadda, MD
Dr. Sadda is Assistant Profesor of Ophthalmology at the Keck School
of Medicine of the Univeristy of Southern California and the Dohney
Eye Insitute. He is Director of the Medical Retina Unit, Ophthalmic
Imaging Unit, Retinal Transplantation Laboratory, and Digital Image
Reading Center. He obtained his M.D. from Johns Hopkins University
and B.S. in Cellular and Molecular Biology from the
University of Michigan. He served as an intern at the W. Beaumont
Hospital and returned to Johns Hopkins University and the Wilmer
Eye Institute for his opthhalmology residency, followed by fellowships
in neuro-opthalmology and medical retina at Wilmer. Dr. Sadda served most recently as a faculty member at the Johns Hopkins Wilmer Eye Institute, where he was a member of the Retinal
Vascular Center and co-Investigator at the Wilmer Photographic Reading
Center.
|
| |
|
 |
Alexander Walsh, MD
Dr. Walsh received his M.D. from Columbia University College of Physicians and Surgeons and completed his internship as an Osler Intern in the Department of Medicine at Johns Hopkins Hospital. Dr. Walsh also completed his Ophthalmology residency at the Wilmer Eye Institute, Johns Hopkins Hospital, followed by a clinical and research fellowship in vitreoretinal surgery at the Doheny Eye Institute, Keck School of Medicine of USC. His clinical interests are the diagnosis and treatment of disorders of the retina. He is also very active in the research and development of ophthalmic imaging devices and instrumentation.
|
|